Patents matching “antibody”

US 12018087

Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject

Dyne Therapeutics, Inc. · Granted Jun 25, 2024 · Expires Jun 20, 2044

US 12018090

PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Rani Therapeutics, LLC · Granted Jun 25, 2024 · Expires Jun 20, 2044

US 12012460

Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide

Dyne Therapeutics, Inc. · Granted Jun 18, 2024 · Expires Jun 13, 2044

US 12006365

Human anti-semaphorin 4D antibody

VACCINEX, INC. · Granted Jun 11, 2024 · Expires Jun 6, 2044

US 11993655

Anti-PD-L1 antibody and use thereof

Oricell Therapeutics Co., Ltd. · Granted May 28, 2024 · Expires May 23, 2044

US 11981724

DNA antibody constructs for use against middle east respiratory syndrome coronavirus

Inovio Pharmaceuticals, Inc. · Granted May 14, 2024 · Expires May 9, 2044

US 11964024

B7H4-targeted antibody-drug conjugates and methods of use thereof

Mersana Therapeutics, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

US 11965032

Anti-CD20 antibody compositions

TG Therapeutics, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

US 11964025

Peptide-containing linkers for antibody-drug conjugates

Mersana Therapeutics, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

US 11939379

Antibody chemically induced dimerizer (AbCID) as molecular switches for regulating cellular therapies

The Regents of the University of California · Granted Mar 26, 2024 · Expires Mar 21, 2044

US 11939377

Affinity matured CD22-specific monoclonal antibody and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 26, 2024 · Expires Mar 21, 2044

US 11932703

Anti-ROR1 antibody and ROR1-targeting engineered cells

Caribou Biosciences, Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

US 11925685

DNA antibody constructs encoding anti-ZIKV envelope antibodies

Inovio Pharmaceuticals, Inc. · Granted Mar 12, 2024 · Expires Mar 7, 2044

US 11912762

Method of treating osteoarthritis by administering an anti-connexin 43 antibody

The Board of Regents of the University of Texas System · Granted Feb 27, 2024 · Expires Feb 22, 2044

US 11912758

Methods of treating metastasis, including inhibiting bone cancer metastasis, by administering an antibody which binds connexin 43 (Cx43) hemichannel

The Board of Regents of the University of Texas System · Granted Feb 27, 2024 · Expires Feb 22, 2044

US 11911435

Stable antibody-drug conjugate, preparation method therefor, and use thereof

GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Feb 27, 2024 · Expires Feb 22, 2044

US 11911434

Stable antibody-drug conjugate, preparation method therefor, and use thereof

GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Feb 27, 2024 · Expires Feb 22, 2044

US 11890353

Anti-polyethylene glycol (PEG) antibody mouse model for rigorous assessment of PEG-based therapies

Northwestern University · Granted Feb 6, 2024 · Expires Feb 1, 2044

US 11884740

Anti-CD20 antibody compositions

TG Therapeutics, Inc. · Granted Jan 30, 2024 · Expires Jan 25, 2044

US 11866491

Antibody for binding to interleukin 4 receptor

SuZhou Connect Biopharmaceuticals, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

US 11866488

Compositions comprising an anti-metallothionein antibody and a pancreatic cell targeting moiety

UNIVERSITY OF CONNECTICUT · Granted Jan 9, 2024 · Expires Jan 4, 2044

US 11845787

DNA antibody constructs for use against HIV

Inovio Pharmaceuticals, Inc. · Granted Dec 19, 2023 · Expires Dec 14, 2043

US 11839660

Anti-transferrin receptor antibody and uses thereof

Dyne Therapeutics, Inc. · Granted Dec 12, 2023 · Expires Dec 7, 2043

US 11834507

Anti-MET agonist antibody for use in the treatment of colorectal cancer

AGOMAB THERAPEUTICS · Granted Dec 5, 2023 · Expires Nov 30, 2043